Clasificación en acciones
#4687
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Capitalización bursátil
$3.41B
Comercio GRAIL Inc. (GRAL)
Precio GRAL con Capital del mercado a B
Capitalización de mercado de GRAIL Inc.(GRAL)
Capitalización bursátil: $3.41B
A fecha de August 2026, GRAIL Inc. tiene una capitalización de mercado de $3.41B. Esto convierte a GRAIL Inc. en la 4687th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de GRAIL Inc. desde 2024 hasta 2026
GRAL en comparación con los más populares 5 títulos stocks
| Precio por GRAL |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.088T
|
+149,210.28%
|
|
|
|
|
$4.629T
|
+135,746.88%
|
|
|
|
|
$4.118T
|
+120,736.31%
|
|
|
|
|
$3.687T
|
+108,091.57%
|
|
|
|
|
$2.800T
|
+82,059.34%
|
